可待因類鎮痛藥市場規模、佔有率和成長分析：按劑型、適應症、通路、最終用戶、處方類型和地區分類－2026-2033年產業預測

2024 年全球可待因鎮痛藥市場價值為 58.2 億美元，預計從 2025 年的 61 億美元成長到 2033 年的 88.8 億美元，預測期（2026-2033 年）的複合年成長率為 4.8%。

全球可待因鎮痛藥市場主要受可待因製劑的生產和消費驅動，這些製劑用於緩解輕度至中度疼痛和止咳。可待因作為一種常用的鴉片類鎮痛藥，每年支持數十億個療程的治療。監管政策的變化影響了市場成長，使可待因成為經濟有效的疼痛管理首選。這一趨勢促使印度等國的可待因產量增加，並推動西歐將可待因納入非處方藥（OTC）範圍。目前，人們對更安全的強效鴉片類藥物替代品的需求日益成長，推動了對複方製劑的投資，這些複方製劑將可待因與非鴉片類藥物結合，在提供有效鎮痛的同時，最大限度地降低濫用風險。此外，東南亞地區處方限制的放寬也擴大了含可待因的非處方藥的市場機會，並吸引了外國投資。

全球可待因類止痛藥市場促進因素

隨著慢性肌肉骨骼疾病的日益普遍，對有效止痛藥的需求也日益成長，可待因已成為治療中重度疼痛的常用鎮痛藥。醫療專業人員越來越認可可待因在緩解長期不適方面的有效性，因此，可待因在基層醫療和專科醫療機構中得到廣泛應用。這種對可待因日益成長的依賴性帶來了穩定的需求，促使生產商加強產能，並投資研發改進配方，以提高患者依從性和治療效果。此外，與效力較強的鴉片類藥物相比，可待因更適合口服給藥，且安全性更高，這些優勢鞏固了其在疼痛管理策略中的地位，並擴大了其在各類醫療機構的市場佔有率。

全球可待因類止痛藥市場面臨的限制因素

全球可待因類鎮痛藥市場面臨諸多阻礙，這主要歸因於衛生監管機構為控制成癮和最大限度減少副作用而實施的嚴格監管。這些監管迫使製藥公司應對複雜的合規體系，包括大量的文件工作、定期的安全評估以及嚴格的標籤要求。因此，產品研發週期延長，營運成本增加，市場進入門檻提高，產品市場定位的柔軟性降低。這種謹慎的市場環境阻礙了市場的快速擴張和新產品的推出，製藥公司不得不將資源投入到監測項目中，最終限制了其有效進入市場的能力。

全球可待因止痛藥市場趨勢

全球含可待因止痛藥市場正呈現顯著成長趨勢，尤其是在新興市場，非處方藥（OTC）的普及率顯著提高。這一趨勢源自於消費者在取得處方箋醫療服務面臨諸多挑戰的情況下，對自我管理止痛方案的需求日益成長。因此，製藥公司正透過藥局和零售連鎖店加強分銷網路，並根據不斷變化的法律規範調整其包裝、品牌和合規策略。為了促進合理用藥，各公司正投資進行針對不同社區（包括都市區和農村地區）的宣傳宣傳活動。遠距藥事照護服務的進步也推動了這一趨勢，凸顯了消費者對便捷止痛藥日益成長的偏好。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球可待因類止痛藥市場規模：以劑型分類。

• 藥片
• 膠囊
• 口服液
• 複方製劑

全球可待因類止痛藥市場規模：依適應症分類

• 輕微疼痛
• 中度疼痛
• 術後疼痛

全球含可待因止痛藥市場規模：依通路分類

• 醫院藥房
• 零售藥房
• 網路藥房

全球含可待因止痛藥市場規模：依最終用戶分類

• 醫院
• 診所
• 居家照護

全球含可待因止痛藥市場規模：依處方類型分類

• 僅限憑處方箋
• 藥局管理計劃

全球含可待因止痛藥市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Teva Pharmaceutical Industries Ltd.
• Viatris Inc.
• Pfizer Inc.
• Sanofi SA
• Mallinckrodt Pharmaceuticals
• Hikma Pharmaceuticals PLC
• Sun Pharmaceutical Industries Limited
• Dr. Reddy's Laboratories Ltd.
• Aurobindo Pharma Limited
• Cipla Limited
• Lupin Limited
• Zydus Lifesciences Limited
• Torrent Pharmaceuticals Ltd.
• Amneal Pharmaceuticals, Inc.
• STADA Arzneimittel AG
• Sandoz Group AG
• Bausch Health Companies Inc.
• Perrigo Company plc
• Endo, Inc.
• Johnson & Johnson

結論與建議

Global Codeine Painkillers Market size was valued at USD 5.82 Billion in 2024 and is poised to grow from USD 6.1 Billion in 2025 to USD 8.88 Billion by 2033, growing at a CAGR of 4.8% during the forecast period (2026-2033).

The global market for codeine painkillers revolves around the production and consumption of codeine-containing formulations, primarily aimed at mild to moderate pain relief and cough suppression. Codeine's prominence as a frequently prescribed opioid analgesic facilitates billions of treatment courses each year. The market's growth has been influenced by regulatory shifts, with codeine becoming a preferred option for cost-effective pain management. This trend has led to increased manufacturing in countries like India and the incorporation of codeine into over-the-counter products in Western Europe. Currently, there is a heightened demand for safer alternatives to stronger opioids, spurring investments in combination products that incorporate non-opioid agents, which offer effective pain relief while minimizing abuse potential. Additionally, the easing of prescription restrictions in Southeast Asia is expanding opportunities for over-the-counter codeine products and attracting foreign investment.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Codeine Painkillers market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Codeine Painkillers Market Segments Analysis

Global codeine painkillers market is segmented by formulation, indication, distribution channel, end user, prescription type and region. Based on formulation, the market is segmented into Tablets, Capsules, Oral Solutions and Combination Products. Based on indication, the market is segmented into Mild Pain, Moderate Pain and Postoperative Pain. Based on distribution channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. Based on end user, the market is segmented into Hospitals, Clinics and Homecare. Based on prescription type, the market is segmented into Prescription Only and Controlled Dispensing Programs. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Codeine Painkillers Market

The increasing prevalence of chronic musculoskeletal disorders has led to a growing demand for effective pain relief, making codeine a commonly prescribed analgesic for moderate to severe pain. Healthcare practitioners are increasingly acknowledging its effectiveness in alleviating long-lasting discomfort, resulting in a broader adoption within both primary care and specialty practices. This rising reliance on codeine contributes to a consistent demand, prompting manufacturers to enhance production capabilities and invest in improved formulations that promote patient adherence and therapeutic effectiveness. Furthermore, the preference for oral administration and the favorable safety profile compared to stronger opioids solidify codeine's position in pain management strategies, bolstering its market presence across various healthcare settings.

Restraints in the Global Codeine Painkillers Market

The Global Codeine Painkillers market faces significant restraints due to stringent regulations imposed by health authorities aimed at curbing dependence and minimizing adverse effects. These regulations require manufacturers to navigate complex compliance frameworks, involving extensive documentation, regular safety assessments, and restrictive labeling practices. Consequently, product development timelines are extended, and operational costs rise, resulting in increased barriers to entry and decreased flexibility in positioning products within the market. This cautious environment discourages rapid market expansion and new product introductions, as pharmaceutical companies must allocate resources towards monitoring programs, ultimately restricting their ability to penetrate the market effectively.

Market Trends of the Global Codeine Painkillers Market

The Global Codeine Painkillers market is experiencing a significant trend toward increased over-the-counter (OTC) accessibility, particularly in emerging markets. This shift stems from rising consumer demand for self-managed pain relief solutions amid challenges in accessing prescription services. As a result, pharmaceutical companies are enhancing distribution through pharmacies and retail chains while adapting their packaging, branding, and compliance strategies to align with evolving regulatory frameworks. To encourage responsible usage, firms are investing in educational campaigns tailored to diverse urban and rural communities. This trend highlights a growing consumer preference for convenient analgesic options, bolstered by advancements in telepharmacy services.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Codeine Painkillers Market Size by Formulation & CAGR (2026-2033)

• Market Overview
• Tablets
• Capsules
• Oral Solutions
• Combination Products

Global Codeine Painkillers Market Size by Indication & CAGR (2026-2033)

• Market Overview
• Mild Pain
• Moderate Pain
• Postoperative Pain

Global Codeine Painkillers Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Codeine Painkillers Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Clinics
• Homecare

Global Codeine Painkillers Market Size by Prescription Type & CAGR (2026-2033)

• Market Overview
• Prescription Only
• Controlled Dispensing Programs

Global Codeine Painkillers Market Size & CAGR (2026-2033)

• North America (Formulation, Indication, Distribution Channel, End User, Prescription Type)
  • US
  • Canada
• Europe (Formulation, Indication, Distribution Channel, End User, Prescription Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Formulation, Indication, Distribution Channel, End User, Prescription Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Formulation, Indication, Distribution Channel, End User, Prescription Type)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Formulation, Indication, Distribution Channel, End User, Prescription Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viatris Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mallinckrodt Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hikma Pharmaceuticals PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aurobindo Pharma Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lupin Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zydus Lifesciences Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Torrent Pharmaceuticals Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amneal Pharmaceuticals, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• STADA Arzneimittel AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sandoz Group AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch Health Companies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Perrigo Company plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endo, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations